Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying saracatinib to see how well it works in treating patients
with metastatic or locally advanced breast cancer that cannot be removed by surgery.
Saracatinib may stop the growth of tumor cells by blocking some of the enzymes needed for
cell growth